Harnessing natural killer T cells to advance cancer immunotherapy for solid tumors
Harnessing natural killer T cells to advance cancer immunotherapy for solid tumors
In the fight against cancer, chimeric antigen receptor (CAR) T cell therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors. A study demonstrates that a different immunotherapy approach utilizing natural killer T cells produced significant antitumor activity in preclinical models of solid tumors.
In the fight against cancer, chimeric antigen receptor (CAR) T cell therapy has achieved notable success in treating blood cancers. However, it has been largely ineffective against solid tumors. A study demonstrates that a different immunotherapy approach utilizing natural killer T cells produced significant antitumor activity in preclinical models of solid tumors.
Welcome to Lakewood Newsbreak, a subsidiary of Lakewood Opinions, LLC. This website is designed o enhance your news delivery. All information belongs to the individual contributor and LNB take no responsibility for any content. We do not sell any information. LNB pulls from over 2,500 RSS news feeds from around the world to bring you the latest updates. Please enjoy.
There are so many Social Media sites out there and they are hard to keep up with. That is why Lakewood Newsbreak has design a Social site design to discuss and post News and World related items of intrest. We are tring to promote feel good news posts to help the world in these harden times. Please be courteous with your comments. Thannk you and enjoy. Please read our Content Policy for any Questions
Notice. Lakewood Newsbreak™ website uses cookies to provide necessary web site functionality, improve your experience and analyze our traffic. By using our website, you agree to its Terms. We do not sell any information